Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Follitropin alfa biosimilar - Gedeon Richter

Next Previous
Drug Profile

Follitropin alfa biosimilar - Gedeon Richter

Alternative Names: AFOLIA; Bemfola; Bemfola Pen; Follitropin alfa solution pre-filled pen; Follitropin alpha biosimilar - Gedeon Richter; Follitropin-alfa; r-hFSH biosimilar - Gedeon Richter; recombinant human follicle-stimulating hormone - Gedeon Richter

Latest Information Update: 23 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator FINOX
  • Developer Fertility Biotech; FINOX; Gedeon Richter
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins; Recombinant proteins
  • Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Female infertility; Male infertility

Most Recent Events

  • 13 May 2025 Granata Bio and Gedeon Richter agree to co-develop Follitropin alfa biosimilar in USA
  • 10 Jul 2018 Gedeon Richter acquires Follitropin alfa biosimilar from Fertility Biotech
  • 30 Nov 2015 Launched for Male infertility in European Union (SC)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top